RxDoctor Payments Data

Daniel Zukowski, DO

Pain Medicine · Detroit, MINPI 1336671916

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (47.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Medtronic at 50.0% of the total. Reporting peaked in 2021 at $10,249 and has fallen 91.0% since, to $919 in 2025. Among pain medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,964in general payments, 2019–2025

Across 124 payments — averaging $169.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$10K
  • Abbott$5K
  • Nevro Corp.$1K
  • Relievant Medsystems, Inc.$982
  • Boston Scientific$715
  • Nalu Medical, Inc.$287
  • plus $2K from 14 others

What the payments were for

  • Grants$10,00048%
  • Travel & lodging$4,56022%
  • Food & beverage$6,40331%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,964 in reported general payments places this provider in the 90th percentile of 139 pain medicine providers in Michigan.

See all pain medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$61,147
Medicare patients
303
Services billed
703

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tizanidine Hcl69$2,328
Mexiletine Hcl24$1,407
Duloxetine Hcl58$856
Gabapentin73$851
Pregabalin38$824
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$360
Memantine Hcl11$357
Celecoxib18$270
Diclofenac Sodium17$269
Methocarbamol14$210
Meloxicam11$35

Paid to pharmacies, not to this prescriber.

Other pain medicine in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →